Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasm of Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT03162224
What this trial is testing

Safety and Efficacy of MEDI0457 and Durvalumab in Participants With Human Papilloma Virus (HPV) Associated Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck CancerHuman Papilloma Virus
MedImmune LLC 35
Testing effectiveness (Phase 2)Ended earlyNCT00319839
What this trial is testing

Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab

Who this might be right for
Head and Neck Cancer
University of California, Irvine 10
Not applicableLooking for participantsNCT06356272
What this trial is testing

Oropharynx (OPX) Biomarker Trial

Who this might be right for
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Oropharyngeal Squamous Cell Carcinoma+8 more
Mayo Clinic 560
Not applicableEnded earlyNCT04077372
What this trial is testing

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Who this might be right for
Gastrointestinal CancerColorectal CancerPancreatic Adenocarcinoma+6 more
Stanford University 12
Testing effectiveness (Phase 2)Ended earlyNCT00872404
What this trial is testing

CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 37
Not applicableStudy completedNCT04086849
What this trial is testing

Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers

Who this might be right for
Head and Neck NeoplasmSquamous Cell Carcinoma of Head and Neck
Sunnybrook Health Sciences Centre 450
Testing effectiveness (Phase 2)Ended earlyNCT06682806
What this trial is testing

PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

Who this might be right for
Advanced Solid TumorEsophageal CancerMetastatic Solid Tumor+2 more
Prelude Therapeutics Incorporated 6
Testing effectiveness (Phase 2)Ended earlyNCT05357898
What this trial is testing

Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 20
Not applicableStudy completedNCT02182804
What this trial is testing

A Diagnostic Study of the Advanced Endoscopy to Detect Early Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
King Chulalongkorn Memorial Hospital 44
Testing effectiveness (Phase 2)Study completedNCT00116909
What this trial is testing

OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy

Who this might be right for
Locally Recurrent or Metastatic Cancer of the Head and NeckMust Have Failed First-Line Therapy
OSI Pharmaceuticals 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07732634
What this trial is testing

RiMO-HNC-NEO1: Phase 2 Study of RiMO-301 and Hypofractionated Radiotherapy With Pembrolizumab for the Neoadjuvant Treatment of Resectable, Locally Advanced Head-Neck Cancer

Who this might be right for
Head and Neck CancerHead CancerNeck Cancer
University of Illinois at Chicago 20
Not applicableNot Yet RecruitingNCT07674706
What this trial is testing

Evaluating the Optimal Timing of Acupuncture for Managing Chemoradiation-induced Xerostomia in Patients With Head and Neck Cancers

Who this might be right for
XerostomiaHead CancerNeck Cancer+3 more
National University Hospital, Singapore 50
Not applicableLooking for participantsNCT07165184
What this trial is testing

Incidence of 107 Lymph Node Metastasis

Who this might be right for
Esophageal Cancer
Fudan University 1,100
Not applicableStudy completedNCT02315989
What this trial is testing

Early-Phase Safety of Proton Therapy Equipment

Who this might be right for
Malignant GliomaHepatocellular CarcinomaHead and Neck Malignant Tumor+1 more
Chang Gung Memorial Hospital 6
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableStudy completedNCT02372890
What this trial is testing

Validation of High-resolution PET/CT for the Pretherapeutic Lymphnode Staging of Head/Neck Cancer

Who this might be right for
Otorhinolaryngeal NeoplasmsCancer of Head and Neck
Insel Gruppe AG, University Hospital Bern 153
Not applicableNot Yet RecruitingNCT05885490
What this trial is testing

IReC-Bio and IReC Registry

Who this might be right for
Head Cancer Neck
Royal Marsden NHS Foundation Trust 10,000,000
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Testing effectiveness (Phase 2)Study completedNCT02273713
What this trial is testing

The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)

Who this might be right for
Esophageal CancerToxicity
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 154
Next Page